Orexigen Therapeutics (OREX)
Orexigen Therapeutics Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -10.41M | -4.307M | -4.58M | -7.568M | -11.60M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.277M | 0.263M | 0.351M | 0.439M | 0.451M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 1.629M | 1.352M | 1.39M | 1.653M | 2.216M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 1.906M | 1.615M | 1.741M | 2.092M | 2.667M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -0.366M | -0.366M | -2.571M | -0.602M | -5.721M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -8.874M | -3.058M | -5.41M | -6.078M | -14.66M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -19.49M | -16.05M | 3.088M | 3.424M | 30.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | 0.07M | 0.00 | 0.269M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -19.49M | -15.98M | 3.088M | 3.693M | 30.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 0.00 | -0.205M | -0.862M | -1.349M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Equity Issued | 0.062M | 86.92M | 0.00 | 0.013M | 0.439M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.062M | 86.92M | -0.205M | -0.849M | -0.91M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -28.30M | 67.88M | -2.527M | -3.234M | 14.71M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 101.75M | 24.93M | 101.75M | 33.87M | 36.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 73.44M | 101.75M | 33.87M | 36.40M | 39.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
